Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol

Fundamental and Clinical Pharmacology

Volumn 18, Issue 4, 2004, Pages 483-491

  Radauceanu, Anca ^a   Boivin, Jean Marc ^b   Bernaud, Corine ^c   Fay, Renaud ^d   Zannad, Faiez ^a  

^a Ctr Hospitalier Univ de Nancy   (France)

^b CIC Gen Practitioners I   (France)

^c PFIZER INC   (United States)

^d Gentilly Serv Methodol Rech Clin   (France)

Author keywords

Amlodipine; Blood pressure measurement; Clinical trial; Hypertension; Valsartan

Indexed keywords

AMLODIPINE; VALSARTAN;

ADULT; AGED; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES; TIME FACTORS; VALINE;

EID: 4544242069     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00269.x     Document Type: Article

References (30)

1. Collins R., Peto R., Godwin J., Macmahon S. Blood pressure and coronary heart disease. Lancet (1990) 336 370-371.
2. Psaty B.M., Smith N.L., Siscovick D.S. et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA (1997) 277 739-745.
3. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other bloodpressure-lowering. Lancet (2000) 356 1955-1964.
4. Casetta I., Granieri E., Fallica E., la Cecilia O., Paolino E., Manfredini R. Patient demographic and clinical features and circadian variation in onset of ischemic stroke. Arch Neurol. (2002) 59 48-53.
5. Casetta I., Granieri E., Portaluppi F., Manfredini R. Circadian variability in hemormagic stroke. JAMA (2002) 287 1266-1267.
6. Mehta R.H., Manfredini R., Hassan F. et al. International Registry of Acute Aortic Dissection (IRAD) Investigators. Chronobiological patterns of acute aortic dissections. Circulation (2002) 106 1110-1115.
7. Siegel D., Lopez J. Trends in antihypertensive drug use in the United States. JAMA (1997) 278 1745-1748.
8. Epstein M. Role of a third generation calcium antagonist in the management of hypertension. Drugs (1999) 57(Suppl. 1) 1-10.
9. Hernandez-Hernandez R. et al. Angiotensin II receptor antagonist role in arterial hypertension. J. Hum. Hypertens. (2002) 16(Suppl. 1) S93-S99.
10. Neutel J.M. The importance of 24-h blood pressure control. Blood Press. Monit. (2001) 6 9-16.
11. Detry J.M.R., Block P., De Backer G., Degaute J.P. Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. Eur. J. Clin. Pharmacol. (1995) 47 477-481.
12. Anwar Y.A., White W.B. Chronotherapeutics for cardiovascular disease. Drugs (1998) 55 631-643.
13. Palatini P., Malacco E., Fogari R. et al. on behalf of the Italian Collaborative Study Group. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension. J. Hypertens. (2001) 19 1691-1696.
14. Palatini P., Malacco E., DiSomme S. et al. Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/ hydrochlorothiazide combination and amlodipine. Eur. J. Clin. Pharmacol. (2002) 57 765-770.
15. Corea L., Cardoni O., Fogari R. et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine. Clin. Pharmacol. Ther. (1996) 60 341-369.
16. Little P. et al. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care. BMJ (2002) 325 258-259.
17. Little P. et al. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ (2002) 325 254-257.
18. Palatini P. Importance of various methods of blood pressure measurement in clinical trials. Curr. Hypertens. Rep. (2000) 2 362-369.
19. Leenen F.H.H., Fourney A., Notman G., Tanner J. Persistence of antihypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life. Br. J. Clin. Pharmacol. (1996) 41 83-88.
20. World Health Organization-International Society of Hypertension. Guidelines for the management of hypertension. J. Hypertens. (1999) 17 151-183.
21. O'Brien E., Mee F., Atkins N., O'Malley K. Accuracy of the SpaceLabs 90927 determined by the British Hypertension Society Protocol. J. Hypertens. (1991) 9 573-574.
22. Campbell N.R., Milkovich L., Burgess E., McKay D.W. Self-measurement of blood pressure: accuracy, patient preparation for readings, technique and equipment. Blood Press. Monit. (2001) 6 133-138.
23. Asmar R., Zanchetti A., on behalf of the Organizing Committee and participants. Guidelines for the use of self-blood pressure monitoring: a summary report of the first international consensus conference. J. Hypertens. (2000) 18 493-508.
24. White W.B. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press. Monit. (2001) 6 63-72.
25. Kario K., Pickering T.G., Umeda Y. et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study. Circulation (2003) 107 1401-1406.
26. Ishimitsu T., Minami J., Yoshii M. et al. Comparison of the effects of amlodipine and losartan on 24-hour ambulatory blood pressure in hypertensive patients. Clin. Exp. Hypertens. (2002) 24 41-50.
27. Zannad F., Bernaud C., Fay R., for the General Physicians Investigators' Group. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. J. Hypertens. (1999) 17 137-146.
28. Nussinovitch N., Rosenberg G., Peleg E., Rosenthal T. A comparative crossover evaluation of amlodipine and nifedipine GITS before and after a missed dose: 48-h blood pressure profiles. Am. J. Hypertens. (2002) 15 580-582.
29. Kaplan N.M. Morning surge in blood pressure. Circulation (2003) 107 1347-1355.
30. Siché J.P. et al. Effects of amlodipine on baroreflex and sympathetic nervous system activity in mild-to-moderate hypertension. Am. J. Hypertens. (2001) 14 424-428.